NARCAN® (naloxone hydrochloride) Nasal Spray is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. NARCAN® Nasal Spray is intended for immediate administration as emergency therapy in settings where opioids may be present.

NARCAN® Nasal Spray is not a substitute for emergency medical care.


NARCAN® Nasal Spray is contraindicated in patients known to be hypersensitive to naloxone hydrochloride.

Seek emergency medical assistance immediately after initial use, keeping the patient under continued surveillance.

Risk of Recurrent Respiratory and CNS Depression: Due to the duration of action of naloxone relative to the opioid, keep the patient under continued surveillance and administer repeat doses of naloxone using a new nasal spray with each dose, as necessary, while awaiting emergency medical assistance.

Risk of Limited Efficacy with Partial Agonists or Mixed Agonists/Antagonists: Reversal of respiratory depression caused by partial agonists or mixed agonists/antagonists, such as buprenorphine and pentazocine, may be incomplete. Larger or repeat doses may be required.

Precipitation of Severe Opioid Withdrawal: Use in patients who are opioid dependent may precipitate opioid withdrawal characterized by body aches, diarrhea, increased heart rate (tachycardia), fever, runny nose, sneezing, goose bumps (piloerection), sweating, yawning, nausea or vomiting, nervousness, restlessness or irritability, shivering or trembling, abdominal cramps, weakness, and increased blood pressure. In neonates, opioid withdrawal may be life-threatening if not recognized and properly treated and may be characterized by convulsions, excessive crying, and hyperactive reflexes. Monitor for the development of opioid withdrawal.

Risk of Cardiovascular (CV) Effects: Abrupt postoperative reversal of opioid depression may result in adverse CV effects. These events have primarily occurred in patients who had pre-existing CV disorders or received other drugs that may have similar adverse CV effects. Monitor these patients closely in an appropriate healthcare setting after use of naloxone hydrochloride.

The following adverse reactions were observed in a NARCAN Nasal Spray clinical study: increased blood pressure, musculoskeletal pain, headache, nasal dryness, nasal edema, nasal congestion, and nasal inflammation.

See Instructions for Use and full prescribing information in the use of this product.

To report SUSPECTED ADVERSE REACTIONS, contact Adapt Pharma, Inc. at 1-844-4NARCAN (1-844-462-7226) or FDA at 1-800-FDA-1088 or

Prescribing Information

About NAPO

image description

The National Association of Police Organizations (NAPO) is a coalition of police unions and associations from across the United States and was organized for the purpose of advancing the interests of America’s law enforcement officers through legislative advocacy, political action and education.

Founded in 1978, NAPO is the strongest unified voice supporting law enforcement officers in the United States. NAPO represents more than 1,000 police units and associations, and more than 241,000 sworn law enforcement officers who share a common dedication to vigorous and effective representation on behalf of our nation’s law enforcement officers.


Flag Ceremony
at NAPO's 38th
Annual Convention 


NAPO's National President Michael McHale and Executive Director William Johnson issued the following statement in response to IACP President Terrence Cunningham's collective apology for American police:

"We are extremely disappointed to see such a poorly thought-out statement. NAPO stands for the notion of individual responsibility, not collective guilt. Such appeasement of the violent anti-police movement is just one more nail in the coffin of American law enforcement. The people who support American police officers aren't looking for an apology. And for the people who hate the police it won't make any difference."


NAPO Participates in
Press Conference
Calling for Action 
the Thin Blue Line Act

NAPO’s President, Mick McHale, Executive Director, Bill Johnson, elected officers and executive board members joined Representatives David Jolly (R-FL), Rich Nugent (R-FL) and several other Members of Congress outside the U.S. Capitol on May 13th, to call for the passage of the Thin Blue Line Act.

“There is a serious and growing trend of armed attacks on law enforcement officers just because of the uniform they wear. Tepid responses to the murders of police officers do nothing to discourage future attacks, which is why the Thin Blue Line Act is so important,” stated Mick McHale.  “Establishing stricter penalties for those who harm law enforcement officers will deter violence against officers and help keep communities safe, which is why it is vital that Congress pass this legislation.”

Representative Jolly’s Thin Blue Line Act (H.R. 814) currently has 48 cosponsors in the House and its companion bill in the Senate (S. 2034), sponsored by Senator Pat Toomey (R-PA) has 23 cosponsors.

The Thin Blue Line Act would make the murder of a police officer, firefighter, or first responder an aggravating factor in death penalty determinations and would be applicable whether the person is murdered on duty, because of the performance of their duty, or because of their status as a public official.  It covers every police officer whether federal, state, or local as well as any firefighter or first responder.  The only requirement is that the homicide provides federal jurisdiction.  This includes the following:

  • The interstate homicide of an officer
  • A homicide of an officer who is serving on a joint federal/state/local taskforce (example: Organized Crime Task Forces, Drug Enforcement Task Forces, Human Trafficking Task Forces)
  • An officer, deputy, firefighter, first responder killed on federal land

The Thin Blue Line Act is a priority for NAPO and we will continue to work with Representative Jolly and Senator Toomey to pass this important legislation.  If you have any questions about this bill, please contact Andy Edmiston at


Source: May 13, 2016, Press Release, Congressman David Jolly


NAPO Honors 2016 Top Cops!






NAPO Victory at U.S. Supreme Court!




Letter to President
& Attorney General Regarding
Extradition of Cop-Killers
From Cuba








NAPO Protest Letter to NFL over Black Panther Half-Time Show



Police Executives Propose Dangerous New Use Of Force Rules For Line Officers









The Myths of Ferguson









View the PDF Here: The Myths of Ferguson        

Message to All NAPO Members and Supporters About the Ferguson, Missouri Incident

View the PDF Here: Message To All NAPO Members



Lincoln Financial GroupNationwideCHL




Phoenix Police Department

Police Officer Phillip Akins


Indianapolis Metropolitan Police Department

Patrolman Ronald Clayton, Jr. 

Patrolman Richard Weaver


Kentucky State Police

Trooper First Class Jason McCowan

Trooper First Class David T. Long

U.S. Marshal Service

Deputy U.S. Marshal Adrian Romaniuk


Boston Police Department

Detective Brian Ball

Police Officer Gregg Bowden

Police Officer James Conley

Police Officer Brian Johnson

Police Officer Janet P. Lewis

Police Officer Dennis Medina

Police Officer John Moynihan

Massachusetts State Police

Trooper William Cameron

New York

New York City Police Department

Police Officer Geraldo W. Casaigne

Police Officer Lauren O’Rourke

New York

New York State Police

Technical Sergeant Jay D. Cook


Philadelphia Police Department

Police Officer Damien Stevenson


Chattanooga Police Department

Field Training Officer Keven Flanagan

Master Patrol Officer Jeff Lancaster

Master Patrol Officer Sean P. O’Brien

Master Patrol Officer Dennis Pedigo, Jr.

Patrol Officer Lucas Timmons

Master Patrol Officer Grover Lee Wilson III


Austin Police Department

Police Officer Carlos Lopez


Fort Worth Police Department

Police Officer Byron Wylie